Close Menu

Books in a Library

T Adewunmi

Five Year Follow-up of Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukaemia in Trinidad and Tobago

The delivery of quality pharmacy services is thought to be important by virtue of its influence on patient’s satisfaction and hence better patient compliance/adherence. This study explores the relationship between patient’s satisfaction with pharmacy services and control of selected chronic diseases. General Hospital is presented. Efficacy, safety and tolerability seem comparable to that reported in developed countries.


Objective: Data on the use of Imatinib (IM) in developing countries remain limited. A retrospective study was done to assess the efficacy and toxicity of IM in treating chronic myeloid leukaemia (CML) in Trinidad and Tobago.

PDF Attachment: 
Journal Sections: 
e-Published: 31 Jan, 2014
Subscribe to RSS - T Adewunmi
Top of Page